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Abstract  
 
Background: Gastroschisis patients’ morbidity is still high, underlining the importance of identifying 
factors associated with adverse outcomes. 
 
Objective: To determine factors influencing gastroschisis patients’ morbimortality during the first 3 
years of life in Centro Hospitalar São João (CHSJ). 
 
Methodology: Records of infants born with gastroschisis between January 2002 and December 2011 
admitted to CHSJ were reviewed. The relation between demographic and clinical data and 
morbimortality during the first 3 years of life, specifically anthropometric evolution and digestive 
outcome, was evaluated. The factors that were compared were simple versus complex gastroschisis and 
primary versus secondary closure. 
 
Results: Forty records were analysed. The survival rate was 92.3%. Patients with complex gastroschisis 
had worse outcomes: hospital stay (median 59 versus 23.5 days), total parenteral nutrition (50 versus 19 
days), total oral intake reached (47 versus 22.5 days), morphine analgesia (9 versus 3 days), intestinal 
occlusion (60% versus 11.8%), perforation (60% versus 0%) and ischaemia (40% versus 0%), sepsis 
(100% versus 32.4%), short bowel syndrome (40% versus 3.1%), laxative need during 1-year follow-up 
(40% versus 0%), weight percentile <5 at 6 months (75% versus 13.6%) and gastrointestinal symptoms 
after the first year of life (OR: 42; 95% CI: 2.01-877.5). Secondary closure patients had worse outcomes: 
start of oral intake (25 versus 11.5 days), total oral intake reached (48 versus 23 days), necrotizing 
enterocolitis (40% versus 2.9%) and mortality (40% versus 2.9%). 
 
Conclusion: Complex gastroschisis and secondary closure were both associated with higher morbidity. 
Secondary closure was also associated with higher mortality. Complex gastroschisis revealed to be a 
predictive factor for higher incidence of gastrointestinal symptoms after the first year of life. Therefore, 
follow-up at least until 3 years of life of patients with complex gastroschisis is recommended. Further 
research is needed to determine management strategies that improve prognosis. 
 
 
 
Keywords: complex gastroschisis, abdominal wall defect, secondary closure, outcome, morbidity, 
follow-up. 
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1. Introduction 
 
Gastroschisis is a congenital abdominal wall defect in which the abdominal viscera herniate through a 
para-umbilical defect, usually to the right of the umbilicus, without a covering membrane. It is a rare 
malformation but its incidence has been increasing worldwide, with the current rate being 4-5 cases per 
10,000 live births.[1-4] 
 
Due to the small number of cases and limited research opportunities, there is still discussion about the 
development of this malformation, hence there are several gastroschisis pathogenesis theories.  To help 
better understand the causes for this multifactorial abnormality, research has pursued the identification 
of the risk factors, with the main one being young maternal age. Other usually considered risk factors 
are geographical region, low socioeconomic status, first pregnancy, previous terminations, poor 
maternal diet, vasoactive medication, smoking and recreational drugs, other environmental factors and 
gene polymorphisms.[1, 2, 4] 
 
Association with other gastrointestinal anomalies has been described, most frequently with intestinal 
atresia, but also intestinal volvulus, perforation or necrosis. It can also be associated with anomalies of 
other systems, such as cryptorchidism.[1, 4, 5] 
 
Prenatal diagnosis can be made starting from the end of the first trimester of pregnancy, usually by 
ultrasound. It allows for multidisciplinary counselling and planned delivery at a tertiary centre.[1, 4] 
 
The initial management of patients with gastroschisis has improved over the years, through neonatal 
intensive care, parenteral nutrition and surgical techniques. This has contributed to a rise in survival 
rates to over 90%.[5-7] However, morbidity is still high, underlining the importance of identifying 
factors associated with adverse outcomes. A documented factor is the presence of intestinal 
complications (atresia, volvulus, perforation or necrosis), leading to the widespread use of the term 
complex gastroschisis to describe these situations. [8-10] Additional research is needed to identify 
outcome predictive factors in order to improve medical care for these patients.[11] 
 
Objective: To determine factors influencing mortality and morbidity during the first 3 years of life of 
infants born with gastroschisis admitted to Centro Hospitalar São João (CHSJ). 
 
 
2. Methodology 
 
This is a retrospective study of all infants born with gastroschisis between January 2002 and December 
2011 admitted to the Neonatal Intensive Care Unit (NICU) of CHSJ, a tertiary referral centre for 
paediatric and neonatal surgery cases in the north of Portugal. Data regarding demographic 
characteristics, neonatal and paediatric hospitalization, surgical treatment and follow-up during the first 
three years of life were obtained from the patients’ medical records. 
 
The relation between demographic and clinical data and the morbimortality during the first three years 
of life, specifically anthropometric evolution and digestive prognosis, was evaluated. 
 
Data concerning partial Graffar classification, family history of malformations and consanguinity, 
mother’s age, gravidity and previous abortions were collected. Data regarding pregnancy included 
twinning, surveillance, smoking, alcohol and recreational drugs consumption, medication, 
complications (oligohydramnios, intrauterine growth restriction, gastroschisis volvulus and other), 
diagnosis (if prenatal, gestational age). Gestational age at birth, place of birth, type of delivery, gender, 
reanimation, meconium aspiration, Apgar score at 1st and 5th minutes, weight, major malformations 
(gastrointestinal atresia, enteric duplication cyst, microcolon, intestinal volvulus, cardiac malformation, 
cryptorchidism), minor anomalies, chromosome anomalies, gastroschisis type (simple or complex), 
herniated organs, time to surgery, type of surgery, time with silo and other surgeries were also obtained. 
For the purpose of this study, major malformation was defined as an anomaly or malformation that 
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creates significant medical problems for the patient or that requires specific surgical or medical 
management.[12]  
 
Morbidity indicators considered included information from the first hospitalization and follow-up. 
Duration of hospital stay, total parenteral nutrition (TPN) duration, start of oral intake, time to total oral 
intake, ventilation, analgesia and sedation, wound dehiscence, intestinal occlusion, bowel perforation, 
bowel ischaemia, necrotizing enterocolitis (NEC), sepsis, cholestasis, multiple organ failure, short 
bowel syndrome and discharge with parenteral nutrition were evaluated. The follow-up was divided into 
two periods, up to one year of life and between one and three years of life, and the variables considered 
were: surgeries for umbilical hernia, intestinal occlusion and intestinal lengthening, gastro-oesophageal 
reflux disease (GERD), intestinal subocclusion, co-morbidities, gastrointestinal symptoms (vomiting, 
diarrhoea, constipation), medication use (prokinetics, laxatives, antacids) and anthropometric evaluation 
(weight and length). The gastrointestinal symptoms were considered if present during at least three 
consecutive months. 
 
Outcomes of patients born with simple gastroschisis were compared with those of patients born with 
complex gastroschisis (defined by the presence of intestinal atresia, necrosis or perforation at birth). 
Similarly, patients who underwent primary closure (single procedure to reduce the herniated organs and 
close the abdominal wall, which could include enterectomy) were compared with those who underwent 
secondary closure (placement of a silo, progressive reduction of the herniated organs and closure at a 
later date). 
 
The statistical analysis was performed using SPSS for Windows, version 20. Continuous variables were 
characterized by mean (± standard deviation) or median (minimum-maximum) if they had symmetric 
or asymmetric distribution, respectively, and categorical variables by absolute and relative frequencies. 
To compare continuous variables parametric tests (independent t test) or non-parametric tests (Mann 
Whitney-U test) were used. Chi-Square, Fisher’s exact test or Monte Carlo’s test were used to compare 
categorical variables. A multivariate analysis by logistic regression was performed to evaluate predictive 
factors of morbidity. A p value less than 0.05 was considered statistically significant. 
 
This study was approved by the ethics commission (Comissão de Ética para a Saúde) of CHSJ. 
 
 
3. Results 
 
3.1. Demographic and clinical data (Tables 1 and 2) 
 
During the study period, there were 40 neonates with gastroschisis admitted to the NICU, 20 male and 
20 female. None of the patients had a family history of malformations. One newborn was transferred to 
another hospital on arrival and only evaluated at this unit during the first minutes of life. 
 
Prenatal diagnosis was made in the majority of the cases (95%). Most births occurred in a tertiary centre 
(95%) and were done by caesarean section (92.5%). The mean gestational age was 35.85 (±1.777) 
weeks. The mean birth weight was 2422.25 (± 502.703) grams. 
 
During hospitalization, 12 (30.8%) patients needed other surgeries. These included silo replacement, 
secondary closures, Ladd procedure, enterostomies and their reversals, enterectomies, adhesion lysis, 
enteroplasty, incisional hernia repair, inguinal hernia repair and ventriculoperitoneal shunt placement. 
 
Compared with patients born with simple gastroschisis, those with complex gastroschisis had a 
significantly lower gestational age (mean 35 versus 36 weeks, p=0.039), higher incidence of major 
malformations (100% versus 15.2%, p=0.001), most of them gastrointestinal (60%), and needed more 
surgeries (80% versus 23.5%, p=0.017). 
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3.2. First hospitalization outcomes (Table 3) 
 
Death occurred in 3 patients, who were all born with simple gastroschisis. All deaths occurred during 
the neonatal period and due to multiple organ failure: 1) The first patient was born at 37 weeks by 
caesarean section. He had an inflammatory “peel” and oedema of the intestinal loops, but there was no 
apparent atresia or perforation. He was submitted to a silo placement after almost 5 hours of life. In the 
first hours after surgery, there were bleeding through the silo base, hemodynamic instability, metabolic 
acidosis, hyponatremia and hyperkalaemia, anuria, anaemia and thrombocytopenia. At the 3rd day of life 
the patient was re-intervened. NEC was verified, which motivated a wide intestinal resection and 
duodenostomy. The patient died when arriving at the NICU after the surgery. 2) The second patient was 
diagnosed at 30 weeks of gestation and born at 32 weeks by caesarean section. Intestinal atresia was 
suspected and bladder, as well as bowel, was herniated. A primary closure was attempted, but due to 
high intra-abdominal pressure a silo placement was done. She developed acute kidney injury, persistent 
hyponatremia, metabolic acidosis and non-responsive hyperkalaemia which caused cardiac arrest, at day 
3 of life. 3) The third patient was born at 39 weeks by emergent caesarean section in apparent death in 
another hospital. He suffered severe perinatal asphyxia which led to hypoxic-ischemic encephalopathy. 
He also developed metabolic acidosis. During transport he suffered hypotension and bradycardia. 
Primary closure was performed. The clinical course was complicated by status epilepticus, acute kidney 
injury and thrombocytopenia, with sudden cardiorespiratory arrest at day 16 of life. 
 
Patients born with complex gastrosquisis stayed longer in the hospital (median 59 versus 23.5 days, 
p=0.009), had more days of TPN (50 versus 19 days, p=0.007) and reached total oral intake later (at 47 
versus 22.5 days of life, p=0.036) than those with simple gastroschisis. Duration of mechanical 
ventilation showed no statistical difference between the groups. The duration of morphine analgesia was 
longer in the complex group (9 versus 3 days, p=0.034). There was a higher incidence of intestinal 
occlusion (60% versus 11.8%, p=0.032), bowel perforation (60% versus 0%, p=0.001) and bowel 
ischaemia (40% versus 0%, p=0.013) in the complex gastroschisis group. In this group, there was also 
a higher incidence of sepsis (100% versus 32.4%, p=0.008), cholestasis (60% versus 38.2%, p=0.631) 
and short bowel syndrome (40% versus 3.1%, p=0.042). 
 
3.3. Follow-up during the first year of life (Table 4) 
 
GERD was present in 12.5% of patients, all with simple gastroschisis. Laxative administration was 
needed by patients with complex gastroschisis (40%, p=0.022). When evaluating growth parameters, a 
bigger difference was seen at 6 months of life. In those born with complex gastroschisis, weight was 
significantly lower (median 6250 versus 6800 grams, p=0.048), with 75% of patients having a weight 
percentile under 5 (versus 13.6%) at 6 months, p=0.028. 
 
3.4. Follow-up during the second and third years of life (Table 5) 
 
Complex gastroschisis was found to greatly increase the risk of gastrointestinal symptoms during this 
two years (OR: 42; 95% CI: 2.01-877.5; p=0.016). Anthropometric variables were not significantly 
different between the groups and there were no infants below the 5th percentile for weight and length at 
36 months. 
 
During the 3-year follow-up, although not statistically significant, a higher percentage of patients with 
complex gastroschisis needed surgery for intestinal occlusion (50% versus 6.3%). Umbilical hernia 
repair was performed in 14.3% of the patients, all born with simple gastroschisis, and only one patient, 
born with complex gastroschisis, underwent intestinal lengthening surgery for short bowel syndrome. 
 
3.5. Outcomes according to surgery type (Table 6) 
 
Only statistically significant differences are shown. Mortality was higher in the secondary closure group 
(40% versus 2.9%). Start of oral intake and time to full enteral feeding occurred later in those who had 
secondary closure (median 25 versus 11.5 days, p=0.025, and 48 versus 23 days, p=0.041, respectively) 
and more patients of this group had NEC (40% versus 2.9%). 
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4. Discussion 
 
The demographic and clinical data obtained showed a low socio-economic status (mostly parents’ 
professions of a lower income or unemployment), a young maternal age, with most of the mothers being 
primigravidas, cigarette smoking during pregnancy in 20% of the mothers and complications in 25% of 
gestations, (intrauterine growth restriction in 40% of them). These data are in line with the literature.[1, 
4] 
 
Risk stratification of infants by categorizing their gastroschisis into simple and complex, as described 
by Molik et al and validated in other studies, provides a simple and readily available manner of 
predicting outcomes for the patients. Infants with complex gastroschisis have more complications, 
longer hospitalization and TPN periods and higher mortality rate.[6, 8-10] 
 
The main factor affecting these patients’ morbidity is the later onset of intestinal function. Therefore, a 
good way to evaluate outcome is by measuring the duration of TPN, start of oral intake and time to 
achieve total oral intake. Additionally, a longer TPN duration increases the risk of complications, such 
as central line sepsis and hepatic dysfunction.[6, 7]  
 
In our study, patients with complex gastroschisis required more than double the days of hospitalization, 
TPN and morphine analgesia, as well as more than twice the time to achieve total oral intake when 
compared with those with simple gastroschisis. Although not statistically significant, start of oral intake 
and duration of mechanical ventilation were also worse for the complex group.  
 
As predicted, there was a higher incidence of complications in the complex group, including intestinal 
occlusion, bowel perforation, bowel ischaemia and short bowel syndrome. Soares et al reported a higher 
incidence of sepsis in premature patients, who generally presented a more complex clinical picture and 
hence needed more elaborate surgical procedures.[5] In accordance, this study verified that the complex 
group not only had a higher incidence of sepsis, as expected due to the longer TPN, but also had a 
significantly lower gestational age at birth and needed more surgeries. This suggests that there may be 
a relationship between low gestational age and complex gastroschisis and a higher risk of developing 
sepsis. 
 
The survival rate in this study was 92.3%, in line with the literature.[1, 4] Since there were only 3 deaths, 
surprisingly all in the simple gastroschisis group, no significant association was found between the type 
of gastroschisis and mortality. 
 
During the first years of life, infants born with gastroschisis will often have nutritional issues. Some 
develop GERD or have symptoms reflecting hypomotility of their gastrointestinal tract. [4] In our study, 
follow-up during the first year of life revealed a higher consumption of laxatives in those born with 
complex gastroschisis when compared with those born with simple gastroschisis, despite the absence of 
a statistically significant difference in constipation prevalence, possibly due to the fact that its presence 
was only considered if symptoms lasted at least 3 months. 
 
The results revealed that complex gastroschisis is a predictive factor for higher incidence of 
gastrointestinal symptoms after the first year of life. Consequently, it is recommended that patients with 
complex gastroschisis be followed until, at least, 3 years of life. 
 
In a study about long term outcomes of gastroschisis, more than half the children required additional 
surgery besides abdominal wall closure. Surgery for intestinal obstruction due to adhesions was required 
in 24% of the cases, typically in the first year and in those with complex gastroschisis.[13] In our study, 
those with complex gastroschisis needed more surgeries during the first hospitalization than those with 
simple gastroschisis. Although not statistically significant, in this group there were also more patients 
that had intestinal occlusion surgery during the first 3 years of life. One patient with short bowel 
syndrome had intestinal lengthening surgery. Harris et al also report procedures to correct umbilical 
hernias and scars in gastroschisis patients.[13] There were no scar revisions in our study, possibly 
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because of the young age of our patients, in whom aesthetic concerns are not yet evident.[13] There 
were umbilical hernia repairs, all in the simple gastroschisis group. 
 
Several studies show that although infants with gastroschisis have a growth delay during the first 2 or 3 
years of life, the outcome is good in 75% of cases.[1, 2, 4] Many factors contribute to foetal growth 
restriction and early postnatal growth delay. A significant factor is thought to be bowel dysfunction, 
thus it is understandable that infants with complex gastroschisis have lower weights as they suffer from 
it for a longer period.[13] In our study, the complex gastroschisis group had lower median weight and 
more patients under the 5th percentile for weight at 6 months of life than the simple gastroschisis group. 
The same trend was verified for length, although not statistically significant. In total, the number of 
patients with weight and length under the 5th percentile decreased progressively, from 23.1% and 32%, 
respectively, at 6 months of life to 0% for both at 36 months. A possible explanation for this progressive 
catch-up growth is the thrifty phenotype hypothesis (the organism adapts in response to the adverse 
intrauterine and postnatal environment). This would mean that these patients are at a higher risk of 
developing type 2 diabetes and obesity when they become older. [13] Long-term follow-up studies 
would be necessary to further explore this hypothesis. 
 
Bradnock et al discuss the comparison between types of surgery as a way to predict the outcome of 
patients with gastroschisis. They concluded that very few studies found differences between the groups. 
Therefore, a multicentre randomised controlled trial that compares primary closure with a preformed 
silo approach in infants suitable for either type of treatment or that identifies factors contributing to the 
selection of the surgery type is needed to determine the optimal initial management strategy and define 
algorithms of care.[3, 6] As expected, our results showed no statistically significant differences for the 
majority of the variables evaluated in the first three years of life. Nevertheless, start of oral intake and 
time to full enteral feeding occurred later for those who had secondary closure, more patients of this 
group had NEC and there was a higher mortality rate (40%). 
 
Soares et al also described a shorter time to achieve full enteral feeding in those who had primary closure, 
justified by the fact that these patients had simple gastroschisis and easier to correct complications.[5] 
However, in our study there was no statistical difference in the type of gastroschisis between those who 
had primary closure and those who had secondary closure. Another study demonstrated that, even in 
those with simple gastroschisis, if they are submitted to secondary closure there is more delay in starting 
oral intake and stopping mechanical ventilation, empiric antibiotic treatment and TPN, as well as a 
longer hospitalization, independently of patient characteristics.[3] 
 
Most studies report a higher complication rate for those who had secondary closure, although one study 
by Martínez Criado et al found the opposite.[14] In our study, there was no statistically significant 
difference for the evaluated complications between the groups, except for NEC which was more 
prevalent in the secondary closure group. 
 
There are some limitations of this retrospective study. Being an observational study, it is possible that 
there are confounding factors, such as individual patients’ characteristics or factors influencing the 
surgical decision. It is from a single centre, meaning a small number of cases, as gastroschisis is a rare 
malformation. It is based on clinical records, which implies that there were some missing data, 
particularly concerning outpatient follow-up, and there may be some unknown and unmeasured factors 
that could have changed the results. 
 
Despite these limitations, this study provides important information about the first three years of life of 
infants born with gastroschisis, which can be used to provide better parent counselling and improve 
patient management and care. 
 
 
5. Conclusion 
 
Risk stratification by type of gastroschisis was validated, showing that those with complex gastroschisis 
had worse outcomes during the first 3 years of life. Secondary closure was associated with higher 
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mortality and some morbidity indicators. Complex gastroschisis is a predictive factor for the 
development of gastrointestinal symptoms after the first year of life. Thus, follow-up of patients with 
complex gastroschisis is recommended at least during 3 years of life. Further research on outcomes is 
needed, especially with longer follow-up and evaluation of other outcomes (neurodevelopmental, 
vitamin or mineral deficiency, bone mass density). Multicentre randomised trials would help reach 
definitive conclusions and determine management strategies to improve gastroschisis patients’ 
prognosis. 
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Annexes 
 
Table 1. Demographic and prenatal data according to gastroschisis type 
 
Total 
(n=40) 
Simple  
gastroschisis 
(n=34) 
Complex 
gastroschisis 
(n=5) 
p 
Maternal education, n (%) 
Basic Education 
Secondary education 
Higher education 
 
6 (54.5) 
1 (9.1) 
4 (36.4) 
 
5 (71.4) 
0 (0) 
2 (28.6) 
 
1 (25) 
1 (25) 
2 (50) 
 
0.569* 
Maternal profession, n (%) 
1st and 2nd degree 
3rd degree 
4th and 5th degree 
Doesn’t have / student / unemployed 
 
6 (15.8) 
2 (5.3) 
12 (31.6) 
18 (47.4) 
 
3 (9.1) 
2 (6.1) 
11 (33.3) 
17 (51.5) 
 
3 (60) 
0 (0) 
1 (20) 
1 (20) 
 
0.999* 
Paternal profession, n (%) 
1st and 2nd degree 
3rd degree 
4th and 5th degree 
Doesn’t have / student / unemployed 
 
4 (10.8) 
6 (16.2) 
22 (59.5) 
5 (13.5) 
 
2 (6.3) 
4 (12.5) 
21 (65.6) 
5 (15.6) 
 
2 (40) 
2 (40) 
1 (20) 
0 (0) 
 
0.406* 
Maternal age (years), median (min-max) 22.5 (15-34) 22 (15-33) 25 (17-34) 0.474¥ 
Primigravida, n (%) 33 (86.8) 28 (87.5) 4 (80) 0.538§ 
Previous abortions, n (%) 4 (10.5) 3 (9.4) 1 (20) 0.456§ 
Smoking during pregnancy, n (%) 4 (20) 3 (18.8) 1 (25) 0.999§ 
Drugs during pregnancy, n (%) 
Corticosteroids 
Antibiotics 
Corticosteroids and antibiotics 
Antiretroviral drugs 
10 (25.6) 
5 (50) 
1 (10) 
3 (30) 
1 (10) 
9 (27.3) 
4 (44.4) 
1 (11.1) 
3 (33.3) 
1 (11.1) 
1 (20) 
1 (100) 
0 (0) 
0 (0) 
0 (0) 
0.999§ 
0.897* 
Gestation complications, n (%) 
Oligohydramnios 
Intrauterine growth restriction 
10 (25) 
2 (20) 
4 (40) 
8 (23.5) 
1 (12.5) 
4 (50) 
2 (40) 
1 (50) 
0 (0) 
0.587§ 
0.387§ 
0.467§ 
Diagnosis, n (%) 
At birth 
Prenatal 
Gestational week, median (min-max) 
 
2 (5) 
38 (95) 
21 (12-36) 
 
1 (2.9) 
33 (97.1) 
20.5 (12-36) 
 
1 (20) 
4 (80) 
22 (21-31) 
 
0.243§ 
 
0.385¥ 
*Monte Carlo’s test, §Fisher’s exact test, ¥Mann-Whitney U test 
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Table 2. Clinical data according to gastroschisis type 
 
Total 
(n=40) 
Simple 
gastroschisis 
(n=34) 
Complex 
gastroschisis 
(n=5) 
p 
Gestational age (weeks), median (min-max) 36 (32-39) 36 (32-39) 35 (32-36) 0.039¥ 
Birth place, n (%) 
Tertiary centre 
Other hospitals 
 
38 (95) 
2 (5) 
 
33 (97.1) 
1 (2.9) 
 
4 (80) 
1 (20) 
 
0.243§ 
Gender, n (%) 
Male 
Female 
 
20 (50) 
20 (50) 
 
17 (50) 
17 (50) 
 
3 (60) 
2 (40) 
 
0.999§ 
Birth weight (grams), median (min-max) 
2445  
(1500-3575) 
2445  
(1500-3575) 
2170  
(1580-2610) 
0.180∞ 
Delivery, n (%) 
Vaginal 
Caesarean section 
 
3 (7.5) 
37 (92.5) 
 
2 (5.9) 
32 (94.1) 
 
1 (20) 
4 (80) 
 
0.345§ 
Reanimation at birth, n (%) 12 (30) 9 (26.5) 3 (60) 0.159§ 
Meconium aspiration, n (%) 6 (15) 5 (14.7) 1 (20) 0.999§ 
Apgar Score at 1st minute <7, n (%) 8 (20) 7 (20.6) 1 (20) 0.999§ 
Apgar Score at 5th minute <7, n (%) 2 (5) 1 (2.9) 1 (20) 0.243§ 
Major malformations, n (%) 
Gastrointestinal atresia 
Enteric duplication cyst 
Microcolon 
Cryptorchidism 
Cardiac malformations 
10 (26.3) 
1 (9.1) 
1 (9.1) 
1 (9.1) 
2 (18.2) 
4 (36.4) 
5 (15.2) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
4 (66.7) 
5 (100) 
1 (20) 
1 (20) 
1 (20) 
2 (40) 
0 (0) 
0.001§ 
0.455§ 
0.455§ 
0.455§ 
0.182§ 
0.061§ 
Minor anomalies, n (%) 26 (68.4) 21 (63.6) 5 (100) 0.158§ 
Chromosome anomalies, n (%) 3 (11.1) 2 (8.4) 1 (33.3) 0.308§ 
Herniated organs, n (%) 
Liver 
Bladder and/or gonads 
 
2 (5.3) 
10 (26.3) 
 
1 (3) 
10 (30.3) 
 
1 (20) 
0 (0) 
 
0.249§ 
0.298§ 
Time to surgery (minutes), median (min-max) 
90 
(0-394) 
98  
(0-394) 
68  
(0-193) 
0.276¥ 
Type of surgery, n (%) 
Primary closure 
Secondary closure (silo) 
 
34 (87.2) 
5 (12.8) 
 
30 (88.2) 
4 (11.8) 
 
4 (80) 
1 (20) 
 
0.517§ 
 
Time with silo (days), median (min-max) 4 (3-20)  7.5 (3-20) 4 (4) 0.999¥ 
Other surgeries, n (%) 12 (30.8) 8 (23.5) 4 (80) 0.017§ 
¥Mann-Whitney U test, §Fisher’s exact test, ∞Independent t test 
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Table 3. Outcome according to gastroschisis type 
 
Total 
(n=40) 
Simple 
gastroschisis 
(n=34) 
Complex 
gastroschisis 
(n=5) 
p 
Hospital stay (days), median (min-max) 24 (3-788) 23.5 (3-166) 59 (24-788) 0.009¥ 
Total parenteral nutrition (days), median (min-max) 21 (0-787) 19 (0-156) 50 (22-787) 0.007¥ 
Start of oral intake (days of life), median (min-max) 12 (5-47) 12 (5-47) 22 (10-45) 0.395¥ 
Total oral intake reached (days of life), median 
(min-max) 
23 (8-156) 22.5 (8-156) 47 (23-65) 0.036¥ 
Mechanical ventilation (days), median (min-max) 4 (0-41) 4 (0-41) 9 (1-14) 0.164¥ 
Analgesia and sedation, n (%) 
Morphine 
Days, median (min-max) 
Paracetamol 
Days, median (min-max) 
Midazolam 
Days, median (min-max) 
 
37 (94.9) 
4 (1-34) 
28 (71.8) 
4 (1-10) 
20 (51.3) 
3 (1-33) 
 
33 (97.1) 
3 (1-34) 
25 (73.5) 
4 (1-10) 
17 (50) 
3 (1-33) 
 
4 (80) 
9 (6-15) 
3 (60) 
4 (2-6) 
3 (60) 
8 (2-14) 
 
0.999§ 
0.034¥ 
0.999§ 
0.889¥ 
0.999§ 
0.258¥ 
Wound dehiscence, n (%) 1 (2.6) 1 (3) 0 (0) 0.999§ 
Intestinal occlusion, n (%) 7 (17.9) 4 (11.8) 3 (60) 0.032§ 
Bowel perforation, n (%) 3 (7.7) 0 (0) 3 (60) 0.001§ 
Bowel ischaemia, n (%) 2 (5.1) 0 (0) 2 (40) 0.013§ 
Necrotizing enterocolitis, n (%) 3 (7.7) 2 (5.9) 1 (20) 0.345§ 
Sepsis, n (%) 16 (41) 11 (32.4) 5 (100) 0.008§ 
Cholestasis, n (%) 16 (41) 13 (38.2) 3 (60) 0.631§ 
Multiple organ failure, n (%) 4 (10.3) 4 (11.8) 0 (0) 0.999§ 
Short bowel syndrome, n (%) 3 (8.1) 1 (3.1) 2 (40) 0.042§ 
Discharge with parenteral nutrition, n (%) 2 (5.6) 1 (3.2) 1 (20) 0.262§ 
Death, n (%) 
Cause of death 
Multiple organ failure 
Age (days), median (min-max) 
3 (7.7) 
 
3 (100) 
3 (3-16) 
3 (8.8) 
 
3 (100) 
3 (3-16) 
0 (0) 
 
0 (0) 
- 
0.999§ 
 
0.999§ 
- 
¥Mann-Whitney U test, §Fisher’s exact test  
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Table 4. 1-year follow-up according to gastroschisis type 
 
Total 
(n=40) 
Simple  
gastroschisis 
(n=34) 
Complex 
gastroschisis 
(n=5) 
p 
GERD, n (%) 4 (12.5) 4 (14.8) 0 (0) 0.999 § 
Intestinal subocclusion, n (%) 2 (6.5) 1 (3.8) 1 (20) 0.301 § 
Comorbidities, n (%) 9 (29) 7 (26.9) 2 (40) 0.613 § 
Gastrointestinal symptoms, n (%) 
Vomiting, n (%) 
Constipation, n (%) 
3 (9.4) 
1 (3.1) 
2 (6.2) 
2 (7.4) 
1 (3.7) 
1 (3.8) 
1 (20) 
0 (0) 
1 (20) 
0.410 § 
0.999 § 
0.301 § 
Medication, n (%) 
Prokinetics, n (%) 
Laxatives, n (%) 
Antacids, n (%) 
9 (29) 
7 (22.6) 
2 (6.5) 
2 (6.5) 
7 (26.9) 
7 (26.9) 
0 (0) 
2 (7.7) 
2 (40) 
0 (0) 
2 (40) 
0 (0) 
0.613 § 
0.562 § 
0.022 § 
0.999 § 
Weight percentile 6M <P5, n (%) 6 (23.1) 3 (13.6) 3 (75) 0.028§ 
Weight percentile 12M <P5, n (%) 4 (16.7) 3 (15) 1 (25) 0.544§ 
Length percentile 6M <P5, n (%) 8 (32) 5 (23.8) 3 (75) 0.081§ 
Length percentile 12M <P5, n (%) 4 (16.7) 2 (10) 2 (50) 0.115§ 
 §Fisher’s exact test, *Monte Carlo’s test, ¥Mann-Whitney U test 
GERD: gastro-oesophageal reflux disease. 
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Table 5. 3-year follow-up according to gastroschisis type 
 
Total 
(n=40) 
Simple  
gastroschisis 
(n=34) 
Complex 
gastroschisis 
(n=5) 
p 
Intestinal subocclusion, n (%) 1 (5.3) 0 (0) 1 (25) 0.211§ 
Comorbidities, n (%) 13 (59.1) 10 (55.6) 3 (75) 0.616§ 
Gastrointestinal symptoms, n (%) 
Diarrhoea 
Constipation 
4 (21.1) 
1 (5.3) 
3 (15.8) 
1 (6.7) 
0 (0) 
1 (6.7) 
3 (75) 
1 (25) 
2 (50) 
0.016§ 
0.211§ 
0.097§ 
Medication (laxatives), n (%) 4 (21.1) 2 (13.3) 2 (50) 0.178§ 
Surgeries, n (%) 6 (28.6) 4 (23.5) 2 (50) 0.544§ 
Umbilical hernia surgery, n (%) 
Age (months), median (min-max) 
3 (14.3) 
7 (2-36) 
3 (17.6) 
7 (2-36) 
0 (0) 
- 
0.999§ 
- 
Intestinal occlusion surgery, n (%) 
Age (months), median (min-max) 
3 (15) 
4 (1.5-34.5) 
1 (6.3) 
1.5 (-) 
2 (50) 
19.25 (4-34.5) 
0.088§ 
0.999¥ 
Intestinal Lengthening surgery, n (%) 
Age (months), median (min-max) 
1 (5) 
34 
0 (0) 
- 
1 (25) 
34 (-) 
0.200§ 
- 
Weight percentile 24M <P5, n (%) 1 (5.6) 1 (7.1) 0 (0) 0.999§ 
Weight percentile 36M <P5, n (%) 0 (0) 0 (0) 0 (0) - 
Length percentile 24M <P5, n (%) 0 (0) 0 (0) 0 (0) - 
Length percentile 36M <P5, n (%) 0 (0) 0 (0) 0 (0) - 
§Fisher’s exact test, *Monte Carlo’s test, ¥Mann-Whitney U test 
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Table 6. Clinical data according to the type of surgery 
 
Total 
(n=40) 
Primary 
closure 
(n=34) 
Secondary 
closure 
(n=5) 
p 
Start of oral intake (days), median (min-max) 12 (5-47) 11.5 (5-45) 25 (22-47) 0.025¥ 
Total oral intake reached (days), median (min-max) 23 (8-156) 23 (8-156) 48 (31-53) 0.041¥ 
Necrotizing enterocolitis, n (%) 3 (7.7) 1 (2.9) 2 (40) 0.038§ 
Death, n (%) 3 (7.7) 1 (2.9) 2 (40) 0.038§ 
¥Mann-Whitney U test, §Fisher’s exact test 
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